Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of vitamin D supplementation on sustained virological response in chronic hepatitis C genotype 4 patients treated by pegylated interferon/ribavirin.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research - 1 Jan 2015

Esmat Gamal, El Raziky Maissa, Elsharkawy Aisha, Sabry Dina, Hassany Mohamed, Ahmed Amal, Assem Noha, El Kassas Mohamad, Doss Wahid

Abstract excerpt

The current standard of care therapy (SOC) for chronic HCV is pegylated interferon/ribavirin (Peg-IFN/RBV). Many reports showed the possible role of vitamin D supplementation in augmenting the response to SOC. The aim of this study was to assess the role of vitamin D supplementation on the response to treatment in chronic HCV genotype 4 patients. One hundred and one chronic HCV patients were classified into two...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholecalciferol
Share to Dietary Supplements

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Liver Cirrhosis

Share to Polyethylene Glycols

Share to Ribavirin

Source

Identifiers

PMID: 25061714
DOI: 10.1089/jir.2014.0060

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of vitamin D supplementation on sustained virological response in chronic hepatitis C genotype 4 patients treated by pegylated interferon/ribavirin.PMID 25061714Read ↗

Effects of vitamin D supplements in patients with chronic hepatitis C: a randomized, multi-center, open label study.Semantic proximity Read ↗

Vitamin D levels in Egyptian HCV patients (genotype 4) treated with pegylated interferon.Semantic proximity Read ↗

Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: a systematic review and meta-analysis.Semantic proximity Read ↗

Effect of vitamin D supplementation on pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b: a randomized controlled trial.Semantic proximity Read ↗

Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study.Semantic proximity Read ↗

Vitamin D deficiency in hepatitis C virus infection: what is old? what is new?Semantic proximity Read ↗

Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C.Semantic proximity Read ↗

Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients.Semantic proximity Read ↗

Vitamin D pathway gene variants and HCV-2/3 therapy outcomes.Semantic proximity Read ↗

Influence of vitamin D-related gene polymorphisms (CYP27B and VDR) on the response to interferon/ribavirin therapy in chronic hepatitis C.Semantic proximity Read ↗

A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C.Semantic proximity Read ↗

Impact of FokI (rs10735810) and BsmI (rs1544410) on Treatment of Chronic HCV Patients With Genotype 4.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.